Company: MDCXW
Filing Date: 2025-04-30
Form Type: 10-K/A
Source: 0001062993-25-008246
Chunk: 41

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-30
Form: 10-K/A
Chunk 41
---
, for the indicated services for each of the last two fiscal years were as follows:

| Financial Year        
 Ending                | Audit Fees(1) 
           ($) | Audit-Related 
   Fees(2) ($) | Tax Fees(3) 
         ($) | All Other Fees(4) 
               ($) |
| December 31, 2024 (5) |      $168,000 |            $0 |          $0 |                $0 |
| December 31, 2024 (6) |      $134,673 |       $36,114 |     $10,213 |            $9,471 |
| December 31, 2023 (7) |      $158,004 |       $12,125 |      $8,178 |                $0 |

29 Notes: (1)Audit Fees include fees for performance of the annual audit of the Company's financial statements, reviews of quarterly financial statements, reviews of periodic reports and reviews of other documents required by legislation or regulation. (2)Audit-Related Fees include fees related to comfort letters, consents and reviews of securities filings. (3)Tax Fees include fees billed for tax compliance, tax advice and tax planning professional services. These services included reviewing tax returns and assisting in responses to government tax authorities. (4)All other fees include aggregate fees billed for professional services which included accounting advice. (5)Aggregate fees for the financial year ending December 31, 2024 billed by EisnerAmper LLP. (6)Aggregate fees for the financial year ending December 31, 2024 billed by MNP LLP. (7)Aggregate fees for the financial year ending December 31, 2023 were billed by MNP LLP. Policy on Audit Committee Preapproval Policies and Procedures Consistent with SEC policies and guidelines regarding audit independence, the Audit Committee is responsible for the pre-approval of all audit and permissible non-audit services provided by our independent registered public accounting firm on a case-by-case basis. Our Audit Committee will preapprove all non-audit services to be provided to us by its external auditors. The Audit Committee may delegate to one or more of its members the authority to preapprove non audit services but preapproval by such member or members so delegated shall be presented to the full Audit Committee at its first scheduled meeting following such preapproval. All of the services relating to the fees in the table above were approved by our Audit Committee. 30

PART IV Item 15. Exhibits, Financial Statement S